Brawn Biotech Limited (BOM:530207)

Brawn Biotech Revenue

In the fiscal year ending March 31, 2026, Brawn Biotech had annual revenue of 169.78M INR with 25.99% growth. Brawn Biotech had revenue of 19.77M in the quarter ending March 31, 2026, a decrease of -12.92%.

• Revenue: 169.78M
• Revenue Growth: +25.99%
• P/S Ratio: 0.34
• Revenue / Employee: 18.86M
• Employees: 9
• Market Cap: 57.01M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	169.78M	35.02M	25.99%
Mar 31, 2025	134.75M	-30.19M	-18.30%
Mar 31, 2024	164.95M	-57.42M	-25.82%
Mar 31, 2023	222.36M	136.15M	157.93%
Mar 31, 2022	86.21M	-263.55M	-75.35%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 15, 2026

Data Sources Report a data error